Target intelligence / Profile preview

Mitogen- and stress-activated kinase 1 (and 2) (MSK1 (MSK2))

Target
MSK1 (MSK2)
Molecular classification
Enzyme, Protein kinase, Mitogen-activated protein kinase-activated protein kinase (MAPKAPK)
01

Overview

**Mitogen- and stress-activated kinases (MSK1 and MSK2)** are nuclear kinases activated by phosphorylation through ERK1/2 or p38 MAPK pathways. They phosphorylate several substrates, including the transcription factor CREB and histone H3, regulating expression of immediate early genes relevant for cellular stress response, inflammation, and neuronal plasticity. In immune cells, MSKs are important anti-inflammatory regulators, modulating the production of cytokines such as IL-10. In neurons, MSKs contribute to synaptic plasticity and cellular proliferation. MSKs are part of the MAPK-activated protein kinase family (MAPKAPK), which forms a key step in signal transmission from surface receptors to changes in gene expression.

Other names
MSK1MSK2ribosomal protein S6 kinase alpha-5RPS6KA5RPS6KA4
02

Mechanism of action

Drugs inhibiting p38 MAPK and ERK1/2 prevent activation of MSK1/2, reducing downstream phosphorylation of CREB and histone H3. Modulation of cytokine production (e.g., enhancing anti-inflammatory IL-10, reducing TNFα, IL-6).

03

Biological functions

Regulation of gene expression via phosphorylation of CREB and histone H3Immediate early gene inductionImmunomodulation (particularly anti-inflammatory effects)Neuronal proliferation and synaptic plasticity
04

Disease associations

Inflammation (anti-inflammatory effects in the immune system)Cancer (via gene expression changes linked to cell proliferation)Neurological disorders (role in neurons)
05

Safety considerations

Modulating MSK activity broadly may impact immune function and neuronal health, given involvement in diverse gene regulation
06

Interacting drugs

There are no widely approved selective MSK1/2 drugs, but some MAPK pathway inhibitors (which act upstream) will affect MSK signaling indirectly, for example, p38 inhibitors and ERK inhibitors
07

Biomarkers

Phosphorylation status of CREBhistone H3downstream cytokine profiles (e.g., IL-10 expression)

Beyond the preview

Go deeper on Mitogen- and stress-activated kinase 1 (and 2) (MSK1 (MSK2)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitogen- and stress-activated kinase 1 (and 2) (MSK1 (MSK2)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call